Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

BackgroundBreast cancer (BC) is the most common malignant disease worldwide. Although the survival rate is improved in recent years, the prognosis is still bleak once recurrence and metastasis occur. It is vital to investigate more efficient biomarkers for predicting the metastasis and relapse of BC...

Full description

Bibliographic Details
Main Authors:	Sen Miao, Gaoda Ju, Chonghua Jiang, Bing Xue, Lihua Zhao, Rui Zhang, Han Diao, Xingzhou Yu, Linlin Zhang, Xiaozao Pan, Hua Zhang, Lijuan Zang, Lei Wang, Tianhao Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Medicine
Subjects:	DYNLT1 breast cancer biomarker prognosis immune checkpoint blocking therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1167676/full

Similar Items

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer
by: Sen Miao, et al.
Published: (2024-02-01)

The role of DYNLT3 in breast cancer proliferation, migration, and invasion via epithelial‐to‐mesenchymal transition
by: Han Wang, et al.
Published: (2023-07-01)

DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer
by: Jianan Zhang, et al.
Published: (2022-07-01)

DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1
by: Ling Huang, et al.
Published: (2023-06-01)

Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer
by: Shuchun Wei, et al.
Published: (2020-02-01)

Effects of dynein light chain Tctex-type 3 on the biological behavior of ovarian cancer
by: Zhou L, et al.
Published: (2019-07-01)

Proteins as the molecular markers of male fertility
by: Eswari Beeram, et al.
Published: (2019-01-01)

Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma
by: Claudia Alexandra Dumitru, et al.
Published: (2021-05-01)

Maternal protein deficiency alters primary cilia length in renal tubular and impairs kidney development in fetal rat
by: Jun Wang, et al.
Published: (2023-07-01)

DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
by: Gaoda Ju, et al.
Published: (2021-08-01)

Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
by: Nicole Trepanowski, MD, et al.
Published: (2023-12-01)

MAP4 mechanism that stabilizes mitochondrial permeability transition in hypoxia: microtubule enhancement and DYNLT1 interaction with VDAC1.
by: Ya-dong Fang, et al.
Published: (2011-01-01)

Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
by: Nayan J Sarma, et al.
Published: (2013-01-01)

High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma
by: Gaoda Ju, et al.
Published: (2021-01-01)

Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors
by: Elham Roshandel, et al.
Published: (2022-03-01)

Specific and Aspecific Molecular Checkpoints as Potential Targets for Dismantling Tumor Hierarchy and Preventing Relapse and Metastasis Through Shielded Cytolytic Treatments
by: Giovanni Manzo
Published: (2021-07-01)

Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer
by: Xinchen QIN, et al.
Published: (2023-04-01)

Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment
by: Kong C, et al.
Published: (2022-11-01)

Case Report: Temporary pacing using active fixation lead and invasive electrophysiology studies for immune checkpoint inhibitor associated reversible advanced atrioventricular block
by: Yifan Wang, et al.
Published: (2024-02-01)

Emerging treatments for reactive cutaneous capillary endothelial proliferation
by: Yi Liu, et al.
Published: (2023-01-01)

Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
by: Michael P. O’Shea, et al.
Published: (2023-09-01)

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
by: Lucia Gelao, et al.
Published: (2014-03-01)

Mycophenolate mofetil for immune checkpoint inhibitor‐related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review
by: Masayuki Ueno, et al.
Published: (2022-09-01)

The effects of different analgesic methods on chronic pain in patients undergoing video-assisted thoracoscopic surgery
by: Xiaoning Zhao, et al.
Published: (2022-10-01)

Editorial: Emerging engineering approaches in cancer immunotherapy
by: Jialu Xu, et al.
Published: (2022-08-01)

Uveal Melanoma Metastasis
by: Ernesto Rossi, et al.
Published: (2021-11-01)

Design and Analysis of an Efficient Energy Algorithm in Wireless Social Sensor Networks
by: Naixue Xiong, et al.
Published: (2017-09-01)

Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or Relapse
by: Maria Effrosyni Livanou, et al.
Published: (2024-03-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy
by: Lucas C. Adam, et al.
Published: (2018-12-01)

Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells
by: Chengguo Li, et al.
Published: (2021-10-01)

Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
by: Hu Chunhong, et al.
Published: (2022-12-01)

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
by: Weijing Cai, et al.
Published: (2018-08-01)

Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
by: Deng Pan, et al.
Published: (2019-11-01)

Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
by: Li Pang, et al.
Published: (2023-03-01)

Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report
by: Peng Zhong, et al.
Published: (2023-03-01)

Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma
by: Beatrice Casadei, et al.
Published: (2020-11-01)

Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis
by: Xingjiang Hu, et al.
Published: (2020-10-01)

Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma
by: Yingying Bao, et al.
Published: (2022-07-01)

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review
by: Yaoyao REN, et al.
Published: (2022-01-01)